Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-037
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
Deadline: February 15, 2026
Opportunity Number: RFA-HG-25-005
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: February 15, 2026
Status: Posted
CFDA Numbers: 93.172
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-228
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.879, 93.172
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
Deadline: September 7, 2027
Opportunity Number: PAR-25-229
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.172, 93.879
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-176
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.351
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-069
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-070
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-124
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-126
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NICHD Small Research Grant Program (R03 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PA-25-125
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-204
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.279
NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-164
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-105
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.121
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-166
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-065
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242, 93.866
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-064
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.866, 93.242
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-039
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-040
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-095
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.393, 93.172
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-096
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.172, 93.393
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
Deadline: March 16, 2026
Opportunity Number: PA-25-246
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: March 16, 2026
Status: Posted
CFDA Numbers: 93.866
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-067
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-066
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-110
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-111
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.865, 93.855, 93.279, 93.313